Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz

QR Code

Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz

Almost 80 to 90% of cancer cells show a high telomerase activity compared to normal, differentiated cells. Telomerase activity in cancer cells depend on several factors: increased hTERT expression, modification of telomerase structural subunits and telomere associated proteins. In contrast to other...

Full description

Bibliographic Details
Main Author:	A.Aziz, Noorfaiza
Format:	Thesis
Language:	English
Published:	2016
Online Access:	https://ir.uitm.edu.my/id/eprint/18627/

Similar Items

Synergistic effects of cisplatin and apigenin on telomerase expression and telomerase activity in TNBC cells / Associate Professor Dr Gabriele Ruth Anisah Froemming and Noorfaiza A.Aziz
by: Froemming, Gabriele Ruth Anisah, et al.
Published: (2015)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
by: Storr, Sarah J., et al.
Published: (2012)

Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
by: Baselga, J., et al.
Published: (2013)

Wnt signaling in triple-negative breast cancer
by: Pohl, S., et al.
Published: (2017)

Profiling of gene and exosomal microRNA as therapy targets and biomarkers of cisplatin resistance in triple negative breast cancer stem cell-like subpopulation
by: Koh, May Zie
Published: (2021)

Investigations of bioresponsive polymers in triple negative breast cancers
by: Monteiro, Patricia
Published: (2019)

Triple negative breast cancer in Asia: An insider's view
by: Wang, C., et al.
Published: (2018)

The role of HOXA5 in triple-negative breast cancer (TNBC)
by: Mahmoud, Rinad
Published: (2021)

Integrative molecular and pathologic profiling of triple negative breast cancer
by: Alsaleem, Mansour
Published: (2021)

Recent advances in nanotheranostics for triple negative breast cancer treatment
by: Thakur, Vikram, et al.
Published: (2019)

The association of ICAM-1 detected by immunohistochemical staining with triple negative and non-triple negative breast carcinoma
by: Chong, Choi Yen, et al.
Published: (2019)

The clonal and mutational evolution spectrum of primary triple-negative breast cancers
by: Shah, S., et al.
Published: (2012)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

The role of sodium driven bicarbonate transporters in triple negative breast cancer metastasis
by: Carroll, Christopher
Published: (2020)

A clinicopathologic study on triple-negative breast cancer patients: HUSM experience
by: Saidin, Usman Sani
Published: (2011)

Genetic determinants of TAC chemotherapy response in triple negative breast cancer patients
by: Aziz, Ahmad Aizat Abdul
Published: (2018)

Apoptotic mechanism of apigenin and rutin in ER+- breast cancer cells, MCF-7 / Roziana Kamaludin
by: Kamaludin, Roziana
Published: (2015)

Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines
by: Khor, Poh Yen, et al.
Published: (2021)

Apoptosis and cell cycle mechanisms of ampelopsin E on triple negative breast cancer cells
by: Abd Rahman, Napsiah
Published: (2017)

Passerini multicomponent reaction: a versatile synthesis of nanomedicines for triple negative breast cancer treatment
by: Travanut, Alessandra
Published: (2021)

Mediation of triple-negative breast cancer cell fate via cellular redox and Wnt signalling
by: Pohl, Sebastian Öther-Gee
Published: (2018)

Targeted delivery of vitamin E TPGS based nanomedicine for treatment of triple negative breast cancer
by: Rajaletchumy, Veloo Kutty
Published: (2015)

Systematic review on the efficacy and safety of ixabepilone-based chemotherapy regimen in triple-negative breast cancer
by: Azizah, Maghfira Rahma, et al.
Published: (2024)

The identification of targeting peptides and tumour associated antigens for the treatment and early detection of triple negative breast cancer
by: Wilde, Megan
Published: (2023)

Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
by: Tieng, Francis Yew Fu, et al.
Published: (2019)

PARP inhibitor combinations with Olaparib for synergistic efficacy in Olaparib-resistant triple-negative breast cancer cells
by: Yusoh, Nur Aininie
Published: (2023)

High CD4+/CD8+ Intratumour Ratio is associated with favourable outcome in triple-negative Breast Cancer
by: Thian, Q.Z., et al.
Published: (2022)

Effects of ampelopsin E towards the invasiveness of triple negative breast cancer cell line, MDA-MB-231
by: Tieng, Francis Yew Fu
Published: (2019)

The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells
by: Etti, Imaobong Christopher, et al.
Published: (2017)

Therapeutic potential of albumin nanoparticles encapsulated visnagin in MDA-MB-468 triple-negative breast cancer cells
by: Alsrhani, Abdullah, et al.
Published: (2023)

In silico investigations and potential approaches of Tectona grandis via targeting MMP-9 for triple negative breast cancer
by: Permana, Sofy, et al.
Published: (2024)

Telomere, telomerase and liver disease
by: Aravinthan, Aloysious D., et al.
Published: (2017)

Modular ssDNA binding and inhibition of telomerase activity by designer PPR proteins
by: Spåhr, H., et al.
Published: (2018)

PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers
by: Chen, L., et al.
Published: (2017)

The anti proliferative properties of tinospora crispa on triple negative breast cancer cell lines / Reyadh Radhi Al-Rashidi
by: Al-Rashidi, Reyadh Radhi
Published: (2013)

Effects of Newcastle disease virus infection on cisplatin-resistant breast cancer cell line
by: Jamal, Mohd Hafifi
Published: (2015)

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
by: Cameron, David, et al.
Published: (2013)

Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple negative breast cancer cells
by: Foo, J. B., et al.
Published: (2016)

Cytotoxicity and mechanisms of action of Zerumbone-loaded nanostructured lipid carrier in triple negative breast cancer cells, MDA-MB-231
by: Hosseinpour, Mahnaz
Published: (2015)

Role of genetic variations of abc (abcb1, abcc1 and abcg2) on triple negative breast cancer susceptibility risk
by: Ing, Yeoh Hao
Published: (2024)